Bozhou Jiuban Electronic Commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Bozhou Jiuban Electronic Commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include JIUBAN. The owner is based in Bozhou, Anhui.

No. 2101,Unit 1,Building 7, Gaosu Shidai

Yaodu Road, Qiaocheng District,

Bozhou, Anhui 236800 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JIUBAN
JIUBAN
Registered 2020

Trademark Classifications

Bozhou Jiuban Electronic Commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Bozhou Jiuban Electronic Commerce Co., Ltd. have?

Bozhou Jiuban Electronic Commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Bozhou Jiuban Electronic Commerce Co., Ltd. file in?

Bozhou Jiuban Electronic Commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Bozhou Jiuban Electronic Commerce Co., Ltd.'s most well-known trademarks?

Bozhou Jiuban Electronic Commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as JIUBAN. These are among 1 currently registered trademark in the portfolio.

What is Bozhou Jiuban Electronic Commerce Co., Ltd.'s trademark registration success rate?

Bozhou Jiuban Electronic Commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.